In the post-COVID era in the U.S., antivaccine messaging and political activism are “franchised with health-freedom communities established in each state to rapidly activate for
In Denmark, electronically delivered letters provided a “low-touch, inexpensive, and highly scalable” way of increasing the uptake of influenza vaccination among older adults, researchers report. Letters
Including support of research in the 3 decades before the pandemic, the U.S. government invested nearly $32 billion in the development, production, and purchase of
The 2022–23 influenza vaccine has provided reasonable protection against infection and hospitalization caused by infection, members of the CDC’s Advisory Committee on Immunization Practices heard
During the early spread of omicron variants in the first quarter of 2022, national data compiled by the CDC show the Janssen/Johnson & Johnson Ad26.COV2.S
In a Sept. 2021 survey of U.S. healthcare practitioners (HCP), large percentages report personally receiving COVID-19 vaccines plus boosters and making strong vaccine recommendations to
In an international, phase 3 trial of 24,966 older adults, a single dose of an AS01E-adjuvanted respiratory syncytial virus (RSV) prefusion F protein–based candidate vaccine (RSVPreF3
In a phase 2b trial of 5,782 older adults, an adenovirus serotype 26 respiratory syncytial virus (RSV) vector encoding a prefusion F (preF) protein (Ad26.RSV.preF) protein
The CDC’s Advisory Committee on Immunization Practices provides consolidated, summarized information in its 2023 immunization schedule for adults aged 19 years or older, published in
COVID-19 caused by the omicron variant (B.1.1.529) during pregnancy is associated with increased maternal morbidity and mortality, particularly in women who are symptomatic or unvaccinated,